Humana (HUM) to Acquire Enclara Healthcare
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
SunTrust Reiterates Hold Rating on Humana (HUM) Following Announced Enclara Acquisition
December 17, 2019 7:53 AM ESTSunTrust analyst David MacDonald reiterated a Hold rating and $370.00 price target on Humana (NYSE: HUM) following the company's announced entry into a definitive agreement to acquire Enclara Healthcare. The deal is expected to close in 1H 2020.
MacDonald views the deal as a nice... More
